rellease ID

Curium Group, PeptiDream and PDRadiopharma Announce Completion of Patient Dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer in Japan

Fri, 12 Jun 2026 23:43:00 +0700

*Completion of patient dosing in the registrational Phase 2 clinical trial for 64Cu-PSMA-I&T - a PET radiopharmaceutical targeting prostate-specific membrane antigen (PSMA) expressed on prostate cancer cells

*Data analysis is now underway to support future regulatory submission in Japan

BOSTON, June 11, 2026 (GLOBE NEWSWIRE) -- Curium Group announced today that together with PeptiDream Inc. and PDRadiopharma Inc., patient dosing has been completed in the registrational Phase 2 clinical trial for 64Cu-PSMA-I&T in Japan.

64Cu-PSMA-I&T is a PET radiopharmaceutical targeting PSMA. 64Cu-PSMA-I&T is being assessed as a PET agent labeled with the radioisotope Copper-64. The trial is conducted under the strategic collaboration between PDRadiopharma, a wholly owned subsidiary of PeptiDream, and Curium, aiming at advancing innovative diagnostic radiopharmaceuticals for prostate cancer in Japan.

The open-label, single-arm Phase 2 study is designed to evaluate the sensitivity, specificity, and safety of 64Cu-PSMA-I&T in Japanese patients newly diagnosed with unfavorable intermediate, high or very high-risk prostate cancer and are scheduled for prostatectomy with pelvic lymph node dissection. The results from this study, together with data from Curium's ongoing global clinical trials, are expected to support future regulatory submission in Japan.

In parallel, Curium announced in February, a registrational clinical trial of the therapeutic counterpart, 177Lu-PSMA-I&T, is being advanced to evaluate its efficacy and safety in patients with metastatic castration-resistant prostate cancer (mCRPC), as part of a theranostic approach.

Renaud Dehareng, CEO of Curium Group commented: "Conducting these trials, in partnership with PeptiDream and PDRadiopharma, marks a significant milestone in our mission to expand access to cutting-edge radiopharmaceuticals to patients with prostate cancer across Asia. By combining Curium's global development expertise with PDRadiopharma's deep local knowledge and infrastructure, we are well-positioned to deliver transformative solutions to patients with prostate cancer in Japan."

Patrick C. Reid, President & CEO of PeptiDream commented: "The completion of patient dosing marks an important milestone in the development of 64Cu-PSMA-I&T in Japan. This program represents a key component of our growing radiopharmaceutical pipeline and our broader theranostics strategy. We would like to thank the patients, investigators and clinical sites for their participation and support."

About Prostate Cancer

Prostate cancer continues to be widely prevalent in Japan. Annually, there are approximately 90,000 ? 100,000 new cases (*1). *1: National Cancer Center Japan

Clinical trial progress

Phase 3 ECLIPSE trial - 177Lu-PSMA-I&T, a PSMA-targeting ligand conjugated with the radioisotope Lutetium-177, has been tested by Curium in a global pivotal Phase 3 ECLIPSE trial (ClinicalTrials.gov identifier; NCT05204927). It reported that the primary endpoint was met, demonstrating a statistically significant and clinically meaningful benefit for patients with mCRPC.

Phase 3 SOLAR RECUR and SOLAR STAGE trial - 64Cu-PSMA-I&T trials are being conducted to diagnose biochemical recurrence of prostate cancer (SOLAR RECUR trial, NCT06235099) and for men newly diagnosed with unfavorable intermediate to very high-risk prostate cancer, electing to undergo surgery (SOLAR STAGE trial, NCT06235151). The first in human Phase 1/2 SOLAR trial met the co-primary endpoints of region-level correct localization rate and patient-level correct detection rate in patients with histologically-proven prostate cancer.

Partnership Details

Under the terms of the partnership, Curium and PDRadiopharma will jointly collaborate on clinical development activities of 64Cu-PSMA-I&T and 177Lu-PSMA-I&T and in Japan, with PDRadiopharma leading regulatory filing, manufacturing, commercialization, and distribution activities in Japan. Curium will continue to lead global development of the two agents and support PDRadiopharma through technology transfer to support the set-up of manufacturing lines in Japan - including a high throughput Copper 64 manufacturing line based on Curium's proprietary technology.

About Curium

Curium Pharma is a leading global radiopharmaceutical company with proven expertise in the development, manufacturing and supply of radiopharmaceuticals that transform the way cancer is diagnosed and treated. Headquartered in Boston with offices around the world, Curium's mission is to find new and better ways to diagnose and treat cancer.

With a global footprint that extends to more than 70 countries, a skilled and dedicated team of over 5,000 employees, and four manufacturing sites, Curium is uniquely qualified to meet the significant supply and distribution of established products that underlie success in the radiopharmaceuticals market. Curium's global leadership is embodied in a diverse and extensive portfolio of over 45 products, that advance patient care for a wide range of cancers.

Curium's pioneering legacy in nuclear medicine is the foundation of the company's dedication to innovation and portfolio expansion to cancer therapeutics, particularly in neuroendocrine tumors and with a late-stage pipeline exploring opportunities in prostate cancer.

To learn more, visit www.curiumpharma.com.

About PeptiDream Inc.

PeptiDream Inc. (Tokyo Stock Exchange Prime Section 4587) is leading the translation of macrocyclic peptides into a whole new class of innovative medicines to address unmet medical needs and improve the quality of life of patients worldwide. In its radiopharmaceutical business, through its wholly-owned subsidiary PDRadiopharma, PeptiDream markets and sells a number of approved radiopharmaceuticals and radiodiagnostics in Japan, as well as leveraging its proprietary Peptide Discovery Platform System (PDPS) technology to discover and develop a deep pipeline of innovative targeted radiotherapeutics and radiodiagnostics, spanning both wholly-owned internal programs and globally partnered programs. In its non-radiopharmaceutical business, PeptiDream is similarly leveraging PDPS to discover and develop a broad and diverse pipeline of investigational peptide therapeutics, peptide drug conjugates (PDC) and multi-functional peptide conjugates (MPC) across an extensive global network of discovery and development partners. PeptiDream is headquartered in Kawasaki, Japan. For more information about our company, science and pipeline, please visit www.peptidream.com/en/

About PDRadiopharma

PDRadiopharma, a wholly-owned subsidiary of PeptiDream from 2022, has been providing high-quality radiopharmaceuticals through the research and development, manufacturing, regulatory and sales as a forerunner in the field in radiopharmaceuticals, since it started its business in 1968. PDRadiopharma currently markets 21 radiodiagnostic products (spanning both SPECT and PET products) and 8 radiotherapeutic products (3 product categories) in Japan. Additionally, PDRadiopharma and PeptiDream are developing a broad pipeline of radiotherapeutics and radiodiagnostics for both the Japan and global markets. For more information about PDRadiopharma, please visit www.pdradiopharma.com/en/

Inquiries:

Curium

Camilla Campell

VP, Head of Global Communications

Email: communications@curiumpharma.com

Website: www.curiumpharma.com

PeptiDream Inc.

Contact: Yuko Okimoto, IR & Corporate Communications

Email: info@peptidream.com

Website: https://www.peptidream.com/en/

X: https://x.com/PeptidreamInc

LinkedIn: https://www.linkedin.com/company/peptidream

PDRadiopharma Inc.

Contact: Noriko Tanaka, General Affairs

Email: s-info-hq@pdradiopharma.com

O2 and Mavenir successfully trial technology to improve call clarity for people with hearing loss

Fri, 12 Jun 2026 23:39:00 +0700

*O2 has successfully trialled new technology to provide clearer phone calls for customers with hearing loss

*The trial was carried out with Mavenir and created a personalised hearing profile for each participant, allowing the network to automatically optimise calls in real time

*Working seamlessly in the background, the technology helped overcome the everyday frustration of struggling to follow phone conversations

READING, United Kingdom, June 11, 2026 (GLOBE NEWSWIRE) -- O2 has carried out a proof-of-concept trial using cutting-edge technology designed to improve phone calls for customers with hearing loss.

The operator partnered with cloud-native network software provider, Mavenir, to test the capability which works seamlessly in the background. Participants use their existing phone and number as usual, with the technology working to improve call clarity by tailoring the call audio to their individual hearing needs in real time.

Participants first completed a short, automated hearing test to identify how they perceive different sound frequencies. This generated a personalised hearing profile, securely linked to their mobile number, enabling the technology to adapt how speech is delivered during calls, so conversations are clearer and easier to follow.

Unlike device-based accessibility features or third-party apps, the optimisation took place within O2's network, allowing participants to make and receive calls as normal while benefiting from clearer, more intelligible audio.

Following the trial, nearly 90% of participants reported improvements in call clarity, helping conversations feel easier to follow and leading to fewer misunderstandings. Participants also noted reduced listening effort and a more natural calling experience.

While still at an early stage, the proof-of-concept trial demonstrates how network-based technology could help improve accessibility and everyday communication for people with hearing loss.

Mary Higgins, who is profoundly deaf and took part in the trial, said: "I usually find phone calls tiring and stressful, even with hearing aids. Making a call without them is almost impossible. Using the technology was a completely different experience, as I could hear clearly without my hearing aids and didn't need to keep asking people to repeat themselves."

Jorge Ribeiro, Director of Core Networks, Virgin Media O2, said: "For many people with hearing loss, making a phone call can be a difficult and frustrating experience. This trial is about using the intelligence within our network to improve that experience without asking customers to do anything differently. We are encouraged by the early results from this proof-of-concept and are excited to explore how this type of technology could support more accessible services for our customers in future."

Brandon Larson, SVP & General Manager, Cloud, AI & IMS Business Strategy, Mavenir, said: "Core networks are a powerful platform for innovation of services and delivering new value to customers. Our partnership with Virgin Media O2 in improving the call experience for their customers with hearing loss is a great example of that."

About Mavenir

Mavenir is enabling intelligent, automated, programmable networks through the development of telco-first, cloud-native, AI-by-design software solutions for mobile operators. The company's deep telco domain expertise has been proven through deployments with 300+ operators globally in over 120 countries, which together serve more than 50% of the world's subscribers. Mavenir combines its deep telco experience with the cloud and IT expertise and data science skillsets essential to solving real customer challenges. Its proven software solutions are AI by design, delivering the AI-native future and operators' evolution to TechCos. For more information, please visit www.mavenir.com

Mavenir PR Contact:

Emmanuela Spiteri

PR@mavenir.com

Copenhagen Expands CopenPay Year-Round and Takes Tourist Rewards Global

Fri, 12 Jun 2026 23:36:00 +0700

Copenhagen's tourist reward scheme will launch as a permanent, year-round platform on June 22, allowing visitors to earn rewards for positive actions, while destinations across Europe, North America, and Australia adopt the concept.

Copenhagen, Denmark, June 11, 2026 (GLOBE NEWSWIRE) -- Wonderful Copenhagen announces that Copenhagen's tourist reward scheme will launch as a permanent, year-round platform on June 22, allowing visitors to earn rewards for positive actions, while destinations across Europe, North America, and Australia adopt the concept.

Jump on a bike to earn a cup of coffee. Collect trash and get a kayak tour for free. Arrive by train and get a sauna experience. CopenPay returns this summer, with no end date, and the popular tourism reward scheme is back to change the way tourists explore Copenhagen, with positive actions replacing traditional sightseeing.

"In a time when tourists around the world are often the target of criticism, Copenhagen's CopenPay provides a new way for tourists to engage with the city in a positive way," says Rikke Holm Petersen, Director of Behaviour at Wonderful Copenhagen. "Inspiration and contribution seem to be the new souvenir."

According to a survey from Booking.com (2025), 69% of tourists wish to do something positive for the destination they visit[1], and more than 30,000 tourists have already participated in CopenPay activities. The initiative has received global recognition, including being named one of the world's best inventions by TIME Magazine in 2025, while the European Commission has highlighted it as "a transition pathway for tourism."

"CopenPay is a modern-day fairytale," says Rikke Holm Petersen. "A slightly crazy idea: that tourists would spend part of their precious holidays doing something good for the city - like collecting litter - in exchange for experiences. And just like in a fairytale, the idea turned out not to be so crazy after all."

New Study: Tourists Are Not Motivated by Rewards but by the Experience

A new evaluation of visitor behaviour created by the analysis agency Maple reveals a surprising insight: tourists are more motivated by the positive actions they take than by the rewards they receive.

Only 23% say they are motivated by the reward itself. By contrast, nearly half - 48% - say their primary motivation is the opportunity to have a unique, meaningful and educational experience. Furthermore, seven out of ten participants say they have changed habits back home.

This insight challenges conventional thinking about behavioural change in tourism. Rather than incentives alone driving action, it is the experience itself that truly motivates visitors.

More Unique Experiences Added Across the City

Based on these insights, CopenPay is expanding its range of experiences - making the program even more engaging and distinctive.

Visitors can take part in a growing number of hands-on exchanges across the city: collect a bag of trash and get a free organic meal at BaneGaarden, upcycle worn clothing at Designmuseum Danmark for free, or arrive by bike and gain access to concerts and discounts on cultural events.

"Our ambition is to make positive engagement with the city something people actively seek out and to give our visitors experiences and learnings, they can bring home. Last year, 7 out of 10 said they changed habits after returning home," says Rikke Holm Petersen.

Transport is a Cornerstone in CopenPay

A journey starts already from your home, and so does CopenPay, which is why transport plays a central role. The initiative rewards visitors who choose to arrive in Copenhagen by train with a variety of incentives, including complimentary bike rentals and cycling lessons, making it easy and safe to experience the city on two wheels. "Copenhagen is the world's number one cycling capital, and with CopenPay we want to give visitors something they can take home with them - while also making it safer for everyone to move around the city," says Rikke Holm Petersen.

Furthermore, tourists arriving in electric vehicles are rewarded with free parking and discounts on charging during their stay.

From Local Pilot to Global Movement

Following the success of CopenPay in Copenhagen, the model was made available free of charge to destinations worldwide in February 2026 under the name DestinationPay, allowing others to adopt and adapt. Since then, more than 350 destinations have been introduced to the model and supported in bringing it to life locally. Several countries including Germany, Italy, France, the USA, Canada, Japan and Australia are already preparing to launch their own initiatives this year, with Berlin having already launched its own.

"We share a lot of the same values and ambitions as Copenhagen, and therefore the CopenPay scheme to encourage positive actions and promote a new mindset amongst visitors is of great potential to the Eryri National Park. Making tourism a force for positive change is something we all should take part in, and the CopenPay model is easily adaptable for the Eryri National Park, so that is something we are actively working on," says Alec Young, Carbon Officer, Eryri National Park.

"The ambition is not just to scale CopenPay, but to inspire a global shift in how tourism is experienced - where engaging positively with a destination becomes part of the journey itself," Rikke Holm Petersen concludes.

Facts about CopenPay

Launched in Copenhagen in 2024 as a pilot initiative

Expanded significantly in 2025

Relaunching in 2026 as a year-round initiative with no end date

Model made freely available to all destinations as "DestinationPay" in November 2025

350+ destinations introduced to the concept worldwide

More than 30,000 participants

100+ participating attractions

59% increase in bike rentals among participants

1,200 kg of trash collected from canals in the pilot

7 out of 10 participants report changed behavior after returning home

Only 23% of participants are motivated by rewards, 48% by meaningful experiences

98% would recommend CopenPay to others

Facts about Copenhagen

More bikes than people

Copenhagen has more bicycles than residents and nearly 400 km of dedicated cycle lanes

Nearly half commute by bike

Around 45% of all trips to work or education are made by bicycle

The world's happiest city

Copenhagen ranked#1 globally in the 2026 Happy City Index

The world's most liveable city

Ranked #1 in the Economist Intelligence Unit Global Liveability Index 2025, and scored 100/100 on stability, reflecting low crime and high levels of trust.

[1] https://news.booking.com/bookingcoms-2025-research-reveals-growing-traveler-awareness-of-tourism-impact-on-communities-both-at-home-and-abroad/

Giuseppe Liverino

Wonderful Copenhagen

glv@woco.dk

DKSH entered a strategic distribution partnership with BridgeBio

Fri, 12 Jun 2026 23:23:00 +0700

DKSH entered a strategic distribution partnership with BridgeBio to support regulatory evaluation and potential patient access to a Transthyretin Stabilizer for ATTR-CM in Australia, Singapore, South Korea, and Taiwan. The partnership combines BridgeBio's biotech innovation and DKSH Healthcare's integrated end-to-end commercialization platform to bring a new treatment option to patients.

SINGAPORE - EQS Newswire - 11 June 2026 - DKSH Business Unit Healthcare, a strategic healthcare business partner and leading provider of Market Expansion Services for pharmaceutical, over-the-counter (OTC), consumer health and medical device companies, has entered a distribution partnership with BridgeBio, a biotechnology company focused on genetic diseases. Under the terms of the agreement, DKSH will be responsible for the distribution and commercialization of the transthyretin stabilizer for ATTR-CM across Australia, Singapore, South Korea, and Taiwan.

Where approved, the product is indicated for the treatment of the cardiomyopathy of wild-type or variant transthyretin-mediated amyloidosis (ATTR-CM) in adults to reduce cardiovascular death and cardiovascular-related hospitalization1. ATTR-CM is a progressive, debilitating disease that diminishes quality of life, causes recurrent hospitalizations, and leads to premature death. This new treatment is not currently approved in the countries covered by this agreement and any commercialization will be subject to applicable regulatory approvals and local regulations.

DKSH will provide end-to-end solutions prioritizing healthcare access to patients, leveraging its expertise in regulatory affairs, medical affairs, market access, and launch excellence, as well as its robust distribution infrastructure and integrated commercial capabilities. DKSH is well positioned to support the introduction of this biotech innovation across the Territory following regulatory approvals.2 3 4

"Our strategic partnership with BridgeBio represents an important milestone as DKSH Healthcare enters a new chapter with a renewed vision for growth. United by a shared commitment to improve outcomes for underserved patients, we are proud to combine BridgeBio's scientific innovation with DKSH Healthcare's industry‑leading, end‑to‑end commercialization platform. Leveraging our deep market expertise, strong capabilities, and trusted execution across complex healthcare systems, we are well positioned to launch this biotech innovation and expand access to important new treatment options reliably, responsibly, and at scale, advancing on our mission to deliver Healthcare for All," said Patrik Grande, Global Head of Business Unit Healthcare, DKSH.

1 FDA, Full Prescribing Information. Available at:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/216540s000lbl.pdf Last accessed March 2026.

2 Lane T, et al. Circulation. 2019;140(1):16-26.

3 Rintell D, et al. Orphanet J Rare Dis. 2021;16(1):70.

4 Nativi-Nicolau J, et al. ESC Heart Fail. 2021;8(5):3875-3884

About DKSH

For more than 160 years, DKSH has been delivering growth for companies in Asia Pacific, Europe, and North America across its Business Units Healthcare, Consumer Goods, Performance Materials, and Technology. As a leading Market Expansion Services provider, DKSH offers sourcing, market insights, marketing and sales, e-commerce, distribution and logistics as well as after-sales services, following its purpose of enriching people's lives. DKSH is a participant of the United Nations Global Compact and adheres to its principles-based approach to responsible business. Listed on the SIX Swiss Exchange, DKSH operates in 35 markets with 26,840 specialists, generating net sales of CHF 11.1 billion in 2025. DKSH Business Unit Healthcare distributes pharmaceuticals, consumer health, over-the-counter products and medical devices. With around 7,580 specialists, the Business Unit generated net sales of CHF 5.8 billion in 2025. www.dksh.com/hec

The issuer is solely responsible for the content of this announcement.

Hashtags: #DKSH

Nissan AMIEO Completes 180-Market Pricing Transformation with Syncron, Ahead of Schedule

Fri, 12 Jun 2026 23:21:00 +0700

Syncron replaces legacy system, giving Nissan's pricing teams the speed and visibility to adapt to changing market conditions

STOCKHOLM, Sweden, June 11, 2026 (GLOBE NEWSWIRE) -- Syncron, a global leader in intelligent aftermarket solutions, today announced that Nissan Africa, Middle East, India, Europe, & Oceania (AMIEO) has completed a full rollout of its parts pricing solution across 40 primary markets and more than 140 export markets, finishing ahead of schedule in Q1 2026 and giving the automaker the modern pricing foundation it needs to treat aftermarket as a strategic growth lever.

"As market conditions evolve faster than ever, we recognized the need to sharpen our approach to parts pricing - moving from reactive to strategic," says Carole Gaultier, Director of Service Marketing & New Ecosystems Aftersales AMIEO at Nissan. "Syncron delivered the project on time and on budget, ensuring continuity with our existing processes while helping us build a faster, more efficient and more strategic approach to parts pricing. We've already seen the impact on time saved, strategy execution and auditing processes. Syncron delivered what was promised."

The Syncron deployment currently covers Nissan's European region and replaces a legacy pricing system - giving Nissan's teams a consistent, scalable foundation for managing parts pricing across one of the most geographically complex regions in the automotive industry.

Syncron CEO Josh Weiss says, "Projects of this scope don't succeed on technology alone. Nissan brought the right team, the right commitment, and a clear vision for what they wanted to achieve. Our job was to match that. Completing a rollout across 180-plus markets ahead of schedule and already seeing results is the outcome you work toward from day one. We're proud of what this team is achieving together."

Turning Aftermarket into a Growth Engine

For automotive OEMs, the aftermarket represents one of the most significant opportunities for sustainable revenue growth. Parts pricing sits at the center of that opportunity, directly influencing margin, customer loyalty, and competitive positioning across the service lifecycle.

Nissan's investment in Syncron reflects the company's commitment to treating aftermarket as a strategic asset and a driver of long-term value. With a modern pricing foundation now in place across its markets, Nissan is strengthening its ability to anticipate market dynamics and execute pricing strategy with greater speed, precision and governance - with early results already visible across the region.

About Nissan AMIEO (Africa, Middle East, India, Europe & Oceania)

Nissan is driven by its long-term vision, "Mobility Intelligence for Everyday Life," bringing advanced technologies into everyday experiences to make mobility safer, smarter and more accessible. Through a customer-centric approach and a focus on innovation, Nissan is transforming how people move, creating more connected, intuitive and rewarding mobility experiences.

The AMIEO region plays a pivotal role in advancing this vision. Across its diverse markets, Nissan is expanding access to electrified mobility, introducing innovative technologies and building strategic partnerships that deliver value to customers and drive sustainable growth.

For more information about Nissan's products, services and commitment to intelligent mobility, visit nissan-global.com. You can also follow us on Facebook, Instagram, Twitter and LinkedIn and see all our latest videos on YouTube

About Syncron

Syncron is the aftermarket growth platform for the world's leading manufacturers. Trusted by customers across more than 80 countries, Syncron powers commercial success in the aftermarket with connected solutions - from service supply chain to parts and service pricing and warranty management. Global heavy equipment and automotive brands rely on Syncron to drive revenue, grow margins, and boost customer outcomes across the service lifecycle.

Learn more at syncron.com

Media Contact

KC Crabtree

karen.crabtree@syncron.com

+1 206.949.2551

DP World Launches First Global Seagrass Restoration Initiative In South Korea

Fri, 12 Jun 2026 23:17:00 +0700

Partnership with Korea Green Foundation and FIRA will help restore seagrass meadows off Geoje Island, supporting marine biodiversity, blue carbon habitats and local communities

BUSAN, SOUTH KOREA - Media OutReach Newswire - 11 June 2026 - DP World has launched its first global seagrass restoration initiative on Geoje Island in South Korea, supporting efforts to restore 2.4 hectares of coastal marine habitat over the next four years and enhancing marine biodiversity.

The initiative in South Korea was formalised through a Memorandum of Understanding (MOU) between DP World, Korea Green Foundation and the Korea Fisheries Resources Agency (FIRA). The MOU establishes a long-term collaboration focused on ongoing monitoring of seagrass meadows, the development of restoration approaches informed by scientific research, and continued cooperation between public, private and community stakeholders in the coastal waters of Dadae Village on Geoje Island.

The partnership was launched on World Ocean Day, with representatives from DP World, Korea Green Foundation, FIRA and the local fishing community helping to transplant approximately 6,000 seagrass shoots along the Dadae coastline. The project aims to restore up to 2.4 hectares of seabed over the next four years and is expected to benefit local communities by supporting marine productivity and fish catch potential.

Glen Hilton, CEO & Managing Director, Asia Pacific, DP World, said: "Healthy oceans are essential to sustainable trade and thriving coastal communities. By restoring seagrass meadows in Geoje, we are helping protect one of nature's most effective blue-carbon ecosystems while supporting marine biodiversity and local livelihoods. Together with the Korea Green Foundation and FIRA, we are supporting research, restoration and community engagement efforts that can deepen our understanding of these valuable marine ecosystems to strengthen the resilience of our coasts for future generations."

Jung Tae-yong, Secretary General, Korea Green Foundation, said: "Seagrass meadows are an invaluable presence in supporting coastal ecosystems. They store carbon, help prevent coastal erosion and act as a breakwater for the ecosystem. This project goes beyond simple environmental protection, bringing together businesses, public institutions and local communities to expand practical marine-conservation models and public awareness of the importance of climate action."

Seagrass meadows provide habitat for a wide range of marine species and contribute to the health of coastal ecosystems. They are recognised as an important blue carbon ecosystem because of their ability to absorb and store carbon naturally, making their protection and restoration an area of growing interest among researchers and conservation organisations.

The project will include ongoing monitoring and evaluation activities led by FIRA, alongside community engagement initiatives designed to support long-term stewardship of the restoration site. The partners also intend to build on the Geoje initiative through continued research, community engagement and public awareness activities that support understanding of marine ecosystems and coastal conservation.

This initiative builds on DP World's broader sustainability efforts to support environmental stewardship and community resilience across Asia Pacific. From our flagship mangrove ecosystem restoration programme in Indonesia ? aligned with DP World's global commitment to restore and protect 280 hectares of mangroves by 2030 ? to watershed rehabilitation initiatives in the Philippines and coral reef restoration in Australia, these efforts reflect a regional commitment to protecting the natural environments that are most critical to local communities.

Through partnerships with governments, non-governmental organisations and local communities, DP World continues to explore practical ways to contribute to the long-term sustainability of the environments in which it operates.

DP World

DP World is reshaping the future of global trade to improve lives everywhere. Operating across six continents with a team of over 125,000 employees, we combine global infrastructure and local expertise to deliver seamless supply chain solutions. From Ports and Terminals to Marine Services, Logistics and Technology, we leverage innovation to create better ways to trade, minimising disruptions from the factory floor to the customer's door.

In Asia Pacific, DP World employs over 11,000 people across 22 geographies. We operate 17 ports and terminals, complemented by a comprehensive suite of end-to-end supply chain solutions ? to connect the region to the rest of the world.

WE MAKE TRADE FLOW

The issuer is solely responsible for the content of this announcement.

Hashtags: #DPWORLD

Washington Blueberries Strengthens Market Presence in Indonesia Through Trade Seminar

Fri, 12 Jun 2026 23:14:00 +0700

JAKARTA, INDONESIA - Media OutReach Newswire - 11 June 2026 - The Washington Blueberry Commission strengthened its market presence in Indonesia through the successful completion of the Washington Blueberries Trade Seminar, held on 29 April 2026 at Park Hyatt Jakarta. The event marked an important step in building trade confidence, market education, and long-term engagement for Washington Blueberries in Indonesia.

The seminar brought together importers, distributors, retailers, foodservice professionals, media, and industry stakeholders for a focused introduction to Washington Blueberries and their potential in the Indonesian market. The event reflected growing interest in premium imported fruits, high-quality ingredients, and broader trade opportunities within Indonesia's evolving food and beverage sector.

The seminar aimed to strengthen understanding of Washington Blueberries among key market players. Attendees were introduced to the quality, versatility, and commercial potential of Washington Blueberries across fresh, frozen, and dried formats, with discussions covering product applications, market opportunities, and future collaboration potential. They benefited from substantive discussions covering product applications, market opportunities, and potential avenues for future collaboration.

The event also welcomed Alan Schreiber, Executive Director of the Washington Blueberry Commission, who presented insights on the export strength of Washington Blueberries and the Commission's active role in advancing international market development. His session underscored the critical importance of market education, trade engagement, and strategic relationship-building in driving the sustained growth of Washington Blueberries throughout Southeast Asia.

"We are excited about the trade opportunities for Washington Blueberries in Indonesia. Washington State offers a premium product that aligns well with growing consumer demand in the country for healthy, high-quality, and great-tasting foods," said Alan Schreiber.

Also present was Bryan Sakuma of Sakuma Brothers Farms, who offered first-hand insights from the grower and exporter perspective. His presentation gave attendees a greater understanding of Washington's blueberry industry, encompassing product quality, supply capabilities, and the concrete opportunities available to Indonesian trade partners.

A key highlight of the seminar was the culinary demonstration by Chef Degan Septoadji, a respected Indonesian chef and television personality best known as a judge on MasterChef Indonesia. Through an inspiring live demonstration, Chef Degan showcased the remarkable ways Washington Blueberries can elevate foodservice, dessert, and menu innovation, helping attendees fully appreciate the fruit's versatility as both a world-class premium ingredient and a compelling consumer-facing product.

"I was pleasantly surprised by the quality of Washington frozen blueberries compared to other frozen blueberries available in the market. They are able to hold their shape and texture very well, making them suitable for a wide range of culinary applications," said Chef Degan Septoadji.

The seminar served as a highly effective platform to introduce Washington Blueberries to key Indonesian market stakeholders, combining immersive product education, guided tasting, and productive trade discussion. It generated strong familiarity with the brand and opened promising conversations about Washington Blueberries' growing role in Indonesia's retail, foodservice, bakery, beverage, and health-focused product categories.

As Indonesian consumers and businesses increasingly seek premium imported fruits, healthier snacking options, and versatile, high-quality ingredients, Washington Blueberries is well positioned to lead growth in both the retail and foodservice channels. The success of the Jakarta seminar reflects the Washington Blueberry Commission's unwavering commitment to market education, relationship-building, and long-term investment in Indonesia.

Looking ahead, the Washington Blueberry Commission will continue to work closely with importers, retailers, foodservice operators, and industry partners to grow awareness and trade confidence for Washington Blueberries, cementing their position as a premier blueberry choice in the Indonesian market.

The issuer is solely responsible for the content of this announcement.

Hashtags: #WashingtonBlueberries

Teva Closes Acquisition of Emalex Biosciences, Strengthening Late-Stage Neuroscience Pipeline and Advancing Pivot to Growth Strategy

Fri, 12 Jun 2026 23:10:00 +0700

Ecopipam, an investigational asset for pediatric Tourette syndrome (TS), is a first-in-class selective dopamine D1 receptor antagonist with a novel mechanism of action and has received FDA Orphan Drug and Fast Track designations.

The acquisition expands Teva's innovative pipeline in a specialized area of neuroscience with significant unmet need and is expected to support near- and long-term growth.

At closing, Teva paid $700 million consideration with the potential for up to an additional $200 million in commercial milestone payments, as well as net sales-based royalties, upon commercialization and subject to regulatory approval.

TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva's acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026.

"This acquisition reflects our Pivot to Growth strategy in action, advancing our innovative pipeline through focused, capital-efficient business development," said Richard Francis, President and Chief Executive Officer of Teva. "It adds a late-stage opportunity with potential to address a significant unmet need in Tourette syndrome, and with our deep neuroscience expertise, we are well-positioned to advance this program."

Emalex Biosciences was created by Paragon Biosciences to develop new treatments for central nervous system disorders. Emalex, supported by Paragon, advanced the asset through clinical development and compiled the NDA submission for pediatric Tourette syndrome.

About Tourette Syndrome

Tourette syndrome is a chronic neuro-developmental disorder characterized by involuntary motor and vocal tics beginning in childhood, often between 5 and 10 years of age. For people living with Tourette syndrome, symptoms can be frequent, visible, and disruptive, affecting everyday life. Current treatment approaches can help, but many patients still do not get the level of control they need, or are limited by side effects, underscoring the need for additional options.

About ecopipam

Ecopipam is a first-in-class investigational compound designed to block dopamine signaling at the D1 receptor. D1 receptor hypersensitivity may contribute to repetitive and compulsive behaviors associated with Tourette syndrome.

Ecopipam has received Orphan Drug and Fast Track designations from the FDA for the treatment of pediatric patients with Tourette syndrome. Orphan Drug designation is reserved for patient populations of 200,000 or fewer.

The Phase 3 Tourette syndrome study results were recently published in JAMA Neurology. The primary efficacy endpoint in the study was time to relapse for pediatric patients stable and responding to ecopipam then randomized to ecopipam or placebo. The study showed statistical significance between ecopipam and placebo for the primary efficacy endpoint in pediatric patients (p = 0.0084). Ecopipam was generally well-tolerated in the study and the most common adverse events related to ecopipam therapy were somnolence (10.2%), insomnia (7.4%), anxiety (6.0%), fatigue (5.6%), and headache (5.1%).

About Teva

Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) is transforming into a leading innovative biopharmaceutical company, enabled by a world-class generics business. For over 120 years, Teva's commitment to bettering health has never wavered. From innovating in the fields of neuroscience and immunology to providing complex generic medicines, biosimilars and pharmacy brands worldwide, Teva is dedicated to addressing patients' needs, now and in the future. At Teva, We Are All In For Better Health. To learn more about how, visit www.tevapharm.com.

Cautionary Note Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which are based on management's current beliefs and expectations and are subject to substantial risks and uncertainties, both known and unknown, that could cause Teva's future results, performance or achievements to differ significantly from that expressed or implied by such forward-looking statements.

All statements other than statements of historical fact are, or may be deemed to be, forward-looking statements. In some cases, you can identify these forward-looking statements by the use of words such as "should," "expect," "anticipate," "developing," "target," "may," "expand," "intend," "plan," "believe" and other words and terms of similar meaning and expression in connection with any discussion of future performance. Important factors that could cause or contribute to such differences include risks and uncertainties relating to: our ability to successfully meet the payment obligations under the acquisition agreement of Emalex; our ability to successfully develop, obtain regulatory approval for and commercialize ecopipam; our ability to successfully compete in the marketplace including our ability to develop and commercialize ecopipam and additional pharmaceutical products; our ability to successfully execute our Pivot to Growth strategy, including to expand our innovative and biosimilar medicines pipeline and profitably commercialize the innovative medicines and biosimilar portfolio, whether organically or through business development, and to execute on our organizational transformation and to achieve expected cost savings; our significant indebtedness, which may limit our ability to incur additional indebtedness, engage in additional transactions or make new investments; and other factors discussed in this press release and in our Quarterly Report on Form 10-Q for the first quarter of 2026 and in our Annual Report on Form 10-K for the year ended December 31, 2025, including in the section captioned "Risk Factors" and "Cautionary Note Regarding Forward Looking Statements."

Forward-looking statements speak only as of the date on which they are made, and we assume no obligation to update or revise any forward-looking statements or other information contained herein, whether as a result of new information, future events or otherwise. You are cautioned not to put undue reliance on these forward-looking statements.

Teva Media Inquiries TevaCommunicationsNorthAmerica@tevapharm.com

Teva Investor Relations Inquiries TevaIR@Tevapharm.com

Bitget CFD Rolls Out Zero-Fee Mode Amid Daily Volume Growth Toward $10B

Fri, 12 Jun 2026 23:09:00 +0700

VICTORIA, Seychelles, June 10, 2026 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange (UEX), today announced the launch of Zero-Fee Mode for Bitget CFD, introducing a commission-free account option designed to make CFD trading more flexible, transparent, and accessible.

The launch comes as Bitget CFD continues to scale rapidly, with daily trading volume reaching $8 billion in May and moving closer to the $10 billion milestone. This growth reflects rising demand for multi-asset trading access, as users increasingly seek efficient ways to trade global markets within a unified platform.

Bitget CFD now offers a dual-account structure that gives users greater control over how they trade. The existing ECN Mode remains available for professional, short-term, and high-frequency traders who prefer tighter spreads with volume-based commissions, while the new Zero-Fee Mode is designed for users who favor a more straightforward cost structure with standard spreads and no trading commissions.

The update is driven by growing user demand and feedback around more intuitive trading experiences. Rather than imposing a single model, Bitget CFD now gives users the flexibility to choose the account type that best matches their capital size, trading strategy, experience level, and personal preferences.

"Multi-asset access is becoming the new standard for trading platforms, and CFD is central to how Bitget is delivering that future," said Gracy Chen, CEO of Bitget. "By introducing Zero-Fee Mode, we are providing users with greater flexibility to engage in global markets, further advancing our mission to make financial opportunities more accessible within a single, integrated ecosystem."

This introduction follows a string of successes for Bitget CFD, including its debut industry honor as the Best Global Multi-Asset Trading Platform at the Online Trading Expo. Previously, the platform noted that non-crypto assets accounted for up to 40% of trading activity on certain days this year. Gold and U.S. indices, such as the NAS100, remain the platform's two most popular trading products, driving overall volume growth.

Within Bitget's UEX vision, Bitget CFD plays a key role in connecting crypto and traditional market access through one integrated trading ecosystem. The addition of Zero-Fee Mode strengthens Bitget's broader effort to make multi-asset trading more accessible, flexible, and aligned with different user needs.

For more information about the launch, visit here.

About Bitget

Bitget is the world's largest Universal Exchange (UEX), serving over 125 million users and offering access to over 2M crypto tokens, 100+ tokenized stocks, ETFs, commodities, FX, and precious metals such as gold. The ecosystem is committed to helping users trade smarter with its AI agent, which co-pilots trade execution. Bitget is driving crypto adoption through strategic partnerships with LALIGA and MotoGP?. Aligned with its global impact strategy, Bitget has joined hands with UNICEF to support blockchain education for 1.1 million people by 2027. Bitget currently leads in the tokenized TradFi market, providing the industry's lowest fees and highest liquidity across 150 regions worldwide.

For more information, visit: Website | Twitter | Telegram | LinkedIn | Discord

For media inquiries, please contact: media@bitget.com

Risk Warning: Digital asset prices are subject to fluctuation and may experience significant volatility. Investors are advised to only allocate funds they can afford to lose. The value of any investment may be impacted, and there is a possibility that financial objectives may not be met, nor the principal investment recovered. Independent financial advice should always be sought, and personal financial experience and standing carefully considered. Past performance is not a reliable indicator of future results. Bitget accepts no liability for any potential losses incurred. Nothing contained herein should be construed as financial advice. For further information, please refer to our Terms of Use.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/bcc77153-f7cf-40a5-8e4a-10979c9f2206

GetYourGuide joins Sagrada Familia for the blessing of the Tower of Jesus Christ as an official collaborator

Fri, 12 Jun 2026 23:03:00 +0700

Pope Leo XIV blesses the completed Tower of Jesus Christ at Barcelona's Sagrada Fam?lia on the 100th anniversary of Antoni Gaud?'s death, making it the world's tallest church?

BARCELONA ? June 10, 2026 - GetYourGuide, the leading platform for unforgettable travel experiences, joins the Sagrada Fam?lia as Pope Leo XIV blesses the completed Tower of Jesus Christ in a ceremony marking the 100th anniversary of architect Antoni Gaud?'s death. GetYourGuide joins as both a long-standing partner and one of 15 official collaborators of the Sagrada Fam?lia 2026 program as part of the company's work to partner with the world's landmarks so generations to come can enjoy these cultural gems.?

The completion of the central tower is the most significant milestone in the basilica's ongoing construction since work began in 1882 and, now, the Sagrada Fam?lia is the tallest church in the world.?

Funded by global visitors and local champions: the importance of partnerships

The Sagrada Fam?lia receives no public subsidy. It is funded entirely by visitors, meaning every ticket, every tour, every booking goes into its construction fund. GetYourGuide has worked with the Sagrada Fam?lia for more than ten years, helping sell millions of tickets to a global audience, and is part of a broader portfolio of trusted partnerships with iconic cultural institutions including the Vatican Museums, the Milan Duomo, and the Brera Gallery.

At the press conference previewing Wednesday's mass and blessing, the basilica's General Director Xavier Mart?nez thanked the program's collaborating partners and spoke directly to its relationship with GetYourGuide, thanking the brand for having " always been by our side."

Gaud? brings the globe to Barcelona

Platform data reflects both the partnership's scale and the momentum around this week's ceremony. Interest in the Sagrada Fam?lia on GetYourGuide is already up more than 150% year-on-year, before the papal visit. Barcelona bookings have grown 23% in the first five months of 2026 alone. Seven of the city's ten most-booked attractions are now Gaud? sites, up from five the year prior, with Gaud?-related activities accounting for more than 60% of total Barcelona bookings on the platform.

Interest is also becoming more global. Travelers from Brazil are up 66%, Turkey up 97%, Japan up 41%. With geopolitical shifts rerouting international travel toward Europe, Barcelona is absorbing many of those visitors.

Responsibility at scale: working with cities and communities

"Gaud? spent his life in service of a vision he knew he would never see completed - that is what it means to build for future generations," said Johannes Reck, GetYourGuide co-founder and CEO, who will attend Wednesday's ceremony alongside co-founder and COO Tao Tao. "Every visitor we bring to the Sagrada Fam?lia is a stakeholder in its survival, and this week we feel the weight and the privilege of carrying that forward."

As crowds at the world's most visited sites increase, GetYourGuide's role has expanded, helping sites and cities manage demand intelligently so that iconic landmarks remain accessible and well-preserved for future generations. In Spain, the company works directly with Barcelona City Hall and neighborhood group Amics de la Rambla to balance the needs of residents and visitors. In Italy, it has worked directly with the city of Florence to ban alcohol-led tours from its platform in the city, and is partnering with the city of Rome to open Gabii to the public for the first time. GetYourGuide is also a member of organizations like CityDNA and the European Travel Commission, helping shape the future of a tourism industry that works for travelers, residents, and the landmarks they love.

The Sagrada Fam?lia 2026 program includes 31 events running from autumn 2025 through Christmas 2026 and funded entirely by patronage, is the most concentrated celebration of his legacy since his death.?

For traveler tips on visiting the Sagrada Fam?lia, check out GetYourGuide's guide on visiting Sagrada Fam?lia.

About GetYourGuide

GetYourGuide is a leading global online marketplace to discover and book experiences worth travelling for. Travellers can use GetYourGuide to find things to do in more than 18,000 cities, including tours from local experts, exclusive access to must-see attractions, as well as immersive bucket-list experiences. More than 50,000 supply partners leverage GetYourGuide's easy-to-use platform to grow their businesses, offering 200,000 experiences to travellers around the world. For more information, follow GetYourGuide on LinkedIn, Instagram and TikTok and visit getyourguide.com.

Bitget Continues Stock Spot Expansion With 30 New Listings Across Leading Market Themes

Fri, 12 Jun 2026 23:00:00 +0700

VICTORIA, Seychelles, June 10, 2026 (GLOBE NEWSWIRE) -- Bitget, the world's largest Universal Exchange, has expanded its stock spot lineup with the listing of 30 new stock spot assets, further widening users' access to traditional market opportunities under the recent launch of Stock 2.0. The newly listed assets include rNASA, rBMNR, rDIS, rROKU, and rLCID, and were made available on June 8, 2026.

The latest additions cover a diverse range of companies and investment themes, spanning space innovation, entertainment, consumer brands, enterprise technology, healthcare, defense, cloud infrastructure, education technology, and electric vehicles. The newly supported assets include Tema Space Innovators ETF, BitMine Immersion Technologies, AbbVie, Automatic Data Processing, BlackSky Technology, BWX Technologies, CAVA Group, Celsius Holdings, Cognex, CRISPR Therapeutics, The Walt Disney Company, DigitalOcean, Duolingo, Guidewire Software, Himax Technologies, Hewlett Packard Enterprise, The Coca-Cola Company, Lucid Group, and Lockheed Martin, among others.

Following the recent integration of 49 U.S. equities and ETFs, as well as the expansion of the Bitget Unified Trading Account to include tokenized stocks as margin assets, this latest update provides users with even broader exposure to established global corporations and emerging growth companies across high-activity market sectors. Bitget enhances the accessibility of traditional financial products alongside its robust crypto and market instrument suites, enabling a more comprehensive investment experience through a single, unified platform.

The addition further strengthens Bitget's Universal Exchange strategy, which brings together crypto assets, stocks, ETFs, commodities, foreign exchange products, precious metals, derivatives, and tokenized financial instruments within a unified trading environment. The platform currently offers access to more than 100 tokenized stocks and ETFs, alongside a growing suite of traditional financial products designed to help users navigate opportunities across global markets.

The announcement follows Bitget's continued expansion across stock perpetuals, CFDs, IPO Prime products, tokenized equities, and Reality, its regulated real-world asset issuance platform. Together, these developments reflect Bitget's broader vision of creating a more connected trading experience across both digital assets and traditional financial markets.

Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees

Fri, 12 Jun 2026 22:55:00 +0700

*New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa

*The IKEA Foundation has committed $7.4m to fund the next stage of DREAMS in Ethiopia while the Conrad N. Hilton Foundation has granted $3.5m in funding for the next stage of DREAMS in Uganda

NAIROBI, Kenya, June 10, 2026 (GLOBE NEWSWIRE) -- New evidence released today shows that a combined approach of entrepreneurship support and market access can significantly reduce extreme poverty among refugees and host communities in East Africa.

Two randomized controlled trials (RCTs) of the DREAMS (Delivering Resilient Enterprises and Market Systems) program-implemented by Village Enterprise and Mercy Corps-found that participating households saw meaningful economic gains within a year, even in some of the world's most challenging refugee settings.

The studies, conducted by independent evaluator IDinsight, found that compared to a control group, DREAMS participants increased:

Monthly household consumption by 17% in Uganda and 9% in Ethiopia

Savings by over 90% in both countries, strengthening financial buffers and resilience to economic and climate shocks

Household assets by 20?24%, as participants acquired livestock, built homes, and invested in tools.

The program reached more than 22,000 households across some of the largest refugee settlements in the world-Rhino Camp and Bidi Bidi in Uganda's West Nile region and three refugee settlements in Dollo Ado, Ethiopia.

DREAMS combines Village Enterprise's 12-month poverty graduation program-which equips ultra-poor households with the skills, financial capital, and mentoring needed to start businesses-with market systems development (MSD), delivered by the global humanitarian and development organization Mercy Corps. MSD promotes connections with local private sector actors in key industries to strengthen local markets.

At a time of unprecedented cuts to humanitarian aid, the findings point to a highly cost-effective, scalable model that supports refugees and host communities to move beyond aid dependence, create sustainable livelihoods, and provide for their families and children.

Mary selling goods at the market in the Bidi Bidi refugee settlement in Uganda with her business associates

Jjumba Martin for Village Enterprise

People participating in DREAMS reported meaningful changes in their lives such as being able to buy more nutrient-rich foods such as beef, fish, and milk, as well as pay for the costs of sending their children to school, including paying for fees, books, and transportation. Viola first arrived in the Bidi Bidi refugee settlement from South Sudan and now owns a hair salon. "I had to carry my one-year-old daughter, and our hunger and fatigue made the journey even harder. We arrived in Uganda with nothing," she said. "I didn't know that I could change like this. I think of the day I fled my home and how far I've come, and I'm amazed."

Nurina, a refugee from Somalia who now lives in Ethiopia, said: "Because of my disability, I used to prefer to stay in one place. I felt isolated. My neighbors used to underestimate me, and I wasn't perceived as important. But now they see that I can earn a living, save money, and provide for my children. They come to me for advice. They ask me to explain what I've learned from Village Enterprise. This program was a turning point for my entire family."

The boost to household assets-20% higher than control groups in Uganda and 24% higher in Ethiopia-included livestock, agricultural tools, and investments in housing and solar panels, as well as furniture such as mattresses, beds, and tables.

A development blueprint

The RCTs have measured the impact of the program in Uganda and Ethiopia, but demonstrate the potential of this solution for the 8.7 million people living in refugee settlements globally.

Recognizing the success of DREAMS, the program will continue to be supported:

In Ethiopia?by the IKEA Foundation, which has committed $7.4 million to fund the next stage of DREAMS and further embed the program into local government systems. A key focus of the grant will be to evaluate why the program works in different contexts, and optimizing the approach to be able to scale in these complex settings.

In Uganda-by the Conrad N. Hilton Foundation's commitment of $3.5 million for DREAMS' next stage through March 2029, as well as an evaluation of how DREAMS can embed into existing early childhood development programs across Uganda, Kenya, Tanzania, and Mozambique.

As climate change and conflict drive increased mass displacement, DREAMS showcases how host countries can support refugees to generate income, create sustainable livelihoods, and contribute to local economies. In both Ethiopia and Uganda, the RCTs found DREAMS is projected to yield twice the value of its costs through increased household consumption and asset accumulation if effects are sustained for five years.

Sazini Mojapelo, CEO of Village Enterprise, said: "At a time when humanitarian budgets are shrinking, we need solutions that deliver real, lasting results for the millions of refugees worldwide. DREAMS shows that with the right support, refugees and host communities living in extreme poverty can build businesses, grow their incomes, and provide for their families-ultimately, reducing their reliance on aid. We're grateful to the IKEA Foundation and the Hilton Foundation for their continued support of this work and helping bring DREAMS to more communities and refugees in Ethiopia and Uganda."

Tjada McKenna, CEO of Mercy Corps, said: "Lasting change doesn't come from aid alone; it comes from access to opportunity. This evidence shows that when refugees are connected to functioning markets, supply chains, and customers, they build, earn, and contribute. If we want a future where everyone can prosper, we need to invest in the systems that make that possible."

Alison Connor, Chief Impact Officer at IDinsight, said: "Rigorous evidence on what works for refugees remains scarce, and this evaluation adds meaningfully to that gap. We tested what happens when poverty graduation and market systems development are combined in refugee settings. Across Uganda and Ethiopia, participating households saw meaningful gains in consumption, income, savings, and assets within months of program completion, at returns that compare favorably to other livelihood programs in the region. As the humanitarian sector faces difficult funding decisions, findings like these can help direct resources toward approaches with a credible evidence base."

Rediet Abiy Kassaye, Programme Manager at the IKEA Foundation, said: "These results show what is possible when refugees and host communities are given the opportunity to rebuild their lives with dignity, stability, and hope. We are proud to support the next phase of DREAMS in Ethiopia and to continue working alongside Village Enterprise and Mercy Corps to help families recover from displacement and create new opportunities for themselves and their communities. Together, we see the potential for small businesses and vibrant local markets to create lasting opportunities for families and communities for generations to come."

Barri Shorey, Senior Program Officer, Refugees, Disasters and Aviation at the Conrad N. Hilton Foundation, said: "DREAMS demonstrates the power of investing in long-term economic solutions for refugees and host communities. We're proud to support the next phase of this work in Uganda because the model helps families build sustainable livelihoods, strengthen household stability, and create healthier futures for their children?a true two generation approach! Integrating DREAMS with early childhood development efforts across East Africa creates an opportunity to support caregivers and young children together, helping families build more secure and productive futures."

Media contact:

villageenterprise@wearesevenhills.com

+44 7388 003595

VinFast launches early booking program for battery-swapping e-motorcycles in the Philippines, accelerating its expansion across Southeast Asia

Fri, 12 Jun 2026 22:53:00 +0700

MANILA, PHILIPPINES - Media OutReach Newswire - 10 June 2026 - VinFast has officially launched the Early Booking Program for three (3) e-motorcycle models in the Philippines, including the VinFast Evo, VinFast Feliz II, and VinFast Viper, less than one month after opening bookings for the same lineup in Indonesia. The launch expands VinFast's all-electric product portfolio in the Philippines while demonstrating the Company's ability to rapidly advance its strategy of developing a comprehensive green mobility ecosystem across Southeast Asia.

From June 10 to July 18, customers in the Philippines can place early orders for VinFast e-motorcycles through the official website at vinfastauto.ph or VinFast dealerships nationwide, with a non-refundable booking fee of only PHP 3,000. During the Early Booking Program period, customers will receive incentives valued at PHP 5,600.

All three e-motorcycle models offer accessible pricing and are accompanied by VinFast's flexible ownership model, allowing customers to choose between battery subscription (with battery swapping privilege), or purchasing vehicles with batteries included, depending on their preferences and usage needs.

Accordingly, the VinFast Evo is priced at PHP 70,000 (with battery subscription), PHP 82,700 (including 1 battery), and PHP 95,400 (including 2 batteries). The VinFast Feliz II is priced at PHP 72,400 (with battery subscription), PHP 85,100 (including 1 battery), and PHP 97,800 (including 2 batteries).

Meanwhile, the VinFast Viper is priced at PHP 81,900 (with battery subscription), PHP 94,600 (including 1 battery), and PHP 107,300 (including 2 batteries).

The first deliveries to customers in the Philippines are expected to begin from July 2026.

Ms. Vo Thi Cam Tu, Managing Director of VinFast E-motorcycles Overseas Market, said: "The Philippines is one of the key markets in VinFast's international electric two-wheeler expansion strategy. The introduction of three battery-swapping e-motorcycle models further expands our product ecosystem in the country while offering more green mobility options tailored to the diverse needs of local consumers. We will continue investing comprehensively in products, infrastructure, and services to make the transition to electric mobility the most natural choice for all Filipinos."

The three new models have been developed to meet the diverse mobility needs of consumers in the Philippines, ranging from daily urban commuting and business purposes to modern and dynamic lifestyle aspirations.

Among them, the VinFast Viper is designed for young customers who favor sporty styling and modern technology. The vehicle is equipped with a range of advanced features, including a Smart Key system with remote vehicle tracking and locating functions, a TFT display, projector headlights, and dual rear shock absorbers with external reservoirs.

Meanwhile, the VinFast Evo and VinFast Feliz II are optimized for practical everyday use, combining agile performance, affordable operating costs, and driving ranges well suited to urban mobility needs.

All three models are equipped with a 5,200W BLDC in-wheel motor. The VinFast Viper and VinFast Feliz II support top speeds of up to 90 km/h, while the VinFast Evo reaches up to 80 km/h.

VinFast e-motorcycles are also developed to global quality standards. The frame is constructed using high-strength steel that meets Japanese standards. The motor and controller system are rated IP67 for water and dust resistance, while the battery complies with the European ECE-R136 safety standard and is covered by a warranty of up to 6 years or 72,000 km.

Each e-motorcycle features two battery compartments positioned beneath the seat, allowing the use of up to two 1.5 kWh LFP batteries. With two fully-charged batteries, the vehicle can travel up to 150 km under standard conditions.

Customers may choose to subscribe to two batteries at a monthly fee of PHP 439 per battery, or purchase vehicles with batteries included, depending on their needs. Battery swapping fees are set at PHP 35 per battery per swap.

In addition to battery swapping, users can also charge batteries directly at home. Through a strategic partnership with global charging infrastructure developer V-Green, VinFast is actively deploying battery-swapping stations across the Philippines to provide customers with a convenient, fast, and optimized ownership experience.

The Philippines is currently one of Southeast Asia's largest two-wheeler markets. Combined with increasingly visible trends toward green transportation solutions, the market is considered well-positioned for the growth of electric motorcycles in the coming years. It is also one of the five key international markets in VinFast's electric two-wheeler expansion plan this year, alongside Indonesia, India, Thailand, and Malaysia.

In recent years, VinFast has gradually established a green mobility ecosystem in the Philippines, Indonesia, India, and other markets through partnerships with local companies, alongside ecosystem partners such as Green GSM and V-Green. In addition to e-motorcycles, VinFast is also developing a diverse portfolio that includes electric vehicles, e-bikes, and e-buses, further expanding consumer choices in the transition toward sustainable transportation on a global scale.

The issuer is solely responsible for the content of this announcement.

Hashtags: #VinFast

Credit Bureau Singapore and Experian Malaysia Sign MOU to Enable Cross-Border Credit Reporting

Fri, 12 Jun 2026 22:48:00 +0700

SINGAPORE - Media OutReach Newswire - 9 June 2026 - Credit Bureau (Singapore) Pte Ltd (CBS) and Experian Information Services (Malaysia) Sdn. Bhd. (Experian Malaysia) have signed a Memorandum of Understanding (MOU) to develop a two-way cross-border credit reporting service between Singapore and Malaysia.

The MOU establishes a framework for collaboration to facilitate consented cross-border credit report applications for individuals with financial footprints in either country. The initiative aims to enhance financial inclusion, strengthen credit risk assessment, and support the growing economic integration between the two neighbouring markets.

Singapore and Malaysia share one of ASEAN's most dynamic economic relationships, with bilateral trade regularly exceeding SGD 100 billion annually. Both countries maintain deep labour, education and business linkages, supported by strong digital infrastructure and rapidly growing digital financial services ecosystems.

The collaboration is strategically aligned with the Johor-Singapore Special Economic Zone (JS-SEZ), which places strong emphasis on digital industries, data-driven enterprises and technology-enabled services. As the digital economy accelerates cross-border business models, including fintech, e-commerce, digital banking and platform-based SMEs, trusted cross-border credit infrastructure will be critical to enabling secure digital onboarding, responsible lending and seamless access to capital across both markets.

Under the MOU, CBS and Experian Malaysia intend to collaborate on a cross-border initiative that enables the structured and secure exchange of individual credit information between the two markets.

The proposed framework will define:

The operational roles of the "Source Bureau" and "Processing Bureau" in generating and facilitating cross-border credit data applications

Secure mechanisms for obtaining and managing consumer consent for a one-time release of the credit report

Personal data protection and compliance safeguards in accordance with applicable laws

Commercial and governance models to support sustainable implementation

For consumers, the initiative is expected to improve access to financial products by enabling lenders to consider verified credit histories of individuals from across the border. This may particularly benefit digital-native workers, entrepreneurs and professionals whose financial footprints span both jurisdictions. As more individuals build financial footprints on both sides of the Causeway, the ability to securely and responsibly reflect their credit history across borders becomes increasingly important. A structured cross-border credit reporting framework can help ensure that consumers are assessed more fairly and comprehensively, rather than being treated as "new-to-credit" applicants when they move between Singapore and Malaysia.

For financial institutions, access to cross-border credit data can provide a more holistic view of an applicant's financial obligations, supporting stronger digital underwriting, reduced cross-border fraud risk and more confident expansion into adjacent markets. Improved cross-border data transparency may also enhance operational efficiency and portfolio resilience in increasingly digital lending environments.

CBS and Experian Malaysia emphasised that data protection, regulatory compliance, and consumer consent are foundational to the initiative. Both parties are committed to working within their respective legal and regulatory frameworks and engaging relevant authorities to facilitate responsible implementation. The MOU also contains confidentiality provisions governing information exchanged in the course of collaboration.

Mr. William Lim, Executive Director of Credit Bureau Singapore, said:

"As individuals and businesses operate more seamlessly across Singapore and Malaysia, credit information systems must evolve to reflect cross-border realities. This collaboration represents an important step towards enabling more seamless and responsible access to credit for consumers."

Ms. Dawn Lai, Chief Executive Officer of Experian Information Services Malaysia, added: "Trusted data collaboration is key to strengthening digital financial ecosystems. By working together, we aim to enhance financial inclusion, improve risk transparency and support sustainable growth across both markets."

Mr. Vincent Yap, CBS Board Chairman & Group Chief Credit Officer, Consumer Credit Risk Management of Oversea-Chinese Banking Corporation, said "The access to cross-border credit data can provide a more comprehensive view of an individual applicant's financial obligations, supporting more accurate risk assessment outcomes, reduced cross-border fraud risk and promote seamless access to capital across both markets."

For media enquiries please contact:

Credit Bureau (Singapore) Pte Ltd

Laura Chia

Marketing Manager

Email: laura.chia@creditbureau.com.sg

Experian

April Ng

Head of Marketing, Southeast Asia & Greater China

Email: april.ng@experian.com

PRecious Communications (for Experian)

Tanaya Chakraborty (Singapore)

Email: tanaya@preciouscomms.com

Ainur Faqihah (Malaysia)

Email: ainur.faqihah@preciouscomms.com

The issuer is solely responsible for the content of this announcement.

Photos: From left to right: Ms. Dawn Lai, Chief Executive Officer of Experian Information Services Malaysia and Mr. William Lim, Executive Director of Credit Bureau Singapore

Hashtags: #Experian

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

Thu, 11 Jun 2026 13:44:00 +0700

New Clinical Data, Patient Reported Outcomes, Real-World Utilization, and Comparative-Effectiveness Models to be Featured in Four Oral and One Poster Presentation

PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or refractory mycosis fungoides and S?zary syndrome, two subtypes of cutaneous T-cell lymphoma, will be featured at the World Congress of Cutaneous Lymphomas (WCCL) in Montr?al, Canada.

Drawing on complementary evidence streams, including patient-reported outcomes, comparative-effectiveness estimates, molecular biomarker signals, and real-world utilization, these analyses collectively provide a more complete understanding of the therapeutic profile and potential of mogamulizumab.

"The research being presented at WCCL reflects our continued commitment to generating evidence beyond initial clinical trials for mogamulizumab in patients with relapsed or refractory mycosis fungoides and S?zary syndrome," said Daniela van Eickels, MD, PhD, MPH, Chief Medical Officer, Kyowa Kirin North America. "In these difficult-to-treat blood cancers, innovative clinical research and real-world data generation is essential to advancing and informing treatment strategies. We look forward to sharing our findings and exchanging ideas with the expert community."

WCCL Presentations:
Improved symptoms and health-related quality of life in patients with mycosis fungoides and S?zary syndrome treated with mogamulizumab in the PROSPER study

Oral Presentation; Scientific Session 8A
Friday, June 26, 3:30-4:30 PM ET

Outcomes in relapsed/refractory mycosis fungoides or S?zary syndrome from the MAVORIC trial mogamulizumab arm versus a real-world Australian cohort receiving vorinostat
(Collaborative Study)

Oral Presentation; Scientific Session 3B

Thursday, June 25, 2:30-3:30 PM ET

Overall survival in patients with mycosis fungoides or S?zary syndrome in Denmark: comparative effectiveness of mogamulizumab versus standard of care

Oral Presentation; Scientific Session 3B
Thursday, June 25, 2:30-3:30 PM ET
Targeted sequencing in patients with relapsed/refractory mycosis fungoides mogamulizumab or S?zary syndrome treated with mogamulizumab in the MOGA-2MG-Q4W clinical trial
Oral Presentation; Scientific Session 4B
Thursday, June 25, 3:40-5:20 PM ET
Mogamulizumab treatment for mycosis fungoides in clinical practice in France: data from the ongoing multicentric prospective observational PROMED study

Exhibit Hall Poster Session
Thursday-Saturday, June 25-27
U.S. POTELIGEO (mogamulizumab-kpkc) Indication

POTELIGEO injection for intravenous infusion is indicated for the treatment of adult patients with relapsed or refractory mycosis fungoides (MF) or S?zary syndrome (SS) after at least one prior systemic therapy.

Important Safety Information

WARNINGS AND PRECAUTIONS

Dermatologic toxicity: Monitor patients for rash throughout the course of treatment. For patients who experienced dermatologic toxicity in Trial 1, the median time to onset was 15 weeks, with 25% of cases occurring after 31 weeks. Interrupt POTELIGEO for moderate or severe rash (Grades 2 or 3). Permanently discontinue POTELIGEO for life-threatening (Grade 4) rash or for any Stevens-Johnson syndrome (SJS) or toxic epidermal necrolysis (TEN).

Infusion reactions: Most infusion reactions occur during or shortly after the first infusion. Infusion reactions can also occur with subsequent infusions. Monitor patients closely for signs and symptoms of infusion reactions and interrupt the infusion for any grade reaction and treat promptly. Permanently discontinue POTELIGEO for any life-threatening (Grade 4) infusion reaction.

Infections: Monitor patients for signs and symptoms of infection and treat promptly.
Autoimmune complications: Interrupt or permanently discontinue POTELIGEO as appropriate for suspected immune-mediated adverse reactions. Consider the benefit/risk of POTELIGEO in patients with a history of autoimmune disease.

Complications of allogeneic HSCT after POTELIGEO: Increased risks of transplant complications have been reported in patients who received allogeneic HSCT after POTELIGEO. Follow patients closely for early evidence of transplant-related complications.

ADVERSE REACTIONS

The most common adverse reactions (reported in ≥10% of patients) with POTELIGEO in the clinical trial were rash, including drug eruption (35%), infusion reaction (33%), fatigue (31%), diarrhea (28%), drug eruption (24%), upper respiratory tract infection (22%), musculoskeletal pain (22%), skin infection (19%), pyrexia (17%), edema (16%), nausea (16%), headache (14%), thrombocytopenia (14%), constipation (13%), anemia (12%), mucositis (12%), cough (11%), and hypertension (10%).

You are encouraged to report suspected adverse reactions to Kyowa Kirin, Inc. at 1-844-768-3544 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Please see additional Important Safety Information in full Prescribing Information as well as Patient Information.***

New Castle Building Products Lowers Fuel Costs by Cutting 25,000 Fleet Miles Annually with Descartes Solution

Thu, 11 Jun 2026 13:33:00 +0700

ATLANTA and LONDON, June 10, 2026 (GLOBE NEWSWIRE) -- Descartes Systems Group (Nasdaq:DSGX) (TSX:DSG), the global leader in uniting logistics-intensive businesses in commerce, announced that New York-based New Castle Building Products, a leading distributor of exterior building materials, has reduced its fleet mileage by approximately 25,000 miles annually using Descartes' route planning and execution solution. By replacing manual planning with data-driven routing, New Castle has lowered fuel consumption and costs, improved route consistency and accuracy and enhanced on-time delivery performance, helping the company meet rising customer expectations while operating a more efficient and scalable distribution network.

"Serving customers across the Northeastern U.S. through a network that spans New York, New Jersey, Connecticut, Massachusetts, Pennsylvania, and Maryland we manage a large fleet with complex multi-stop routes, variable jobsite constraints and tight delivery windows," said Keith Haskell, COO at New Castle Building Products. "Before Descartes, route planning was much more manual and decentralized, making it difficult to consistently optimize deliveries across locations. As demand increased, we needed a smarter way to improve planning efficiency and control costs without compromising service standards. With Descartes, we've been able to take approximately 25,000 miles out of our routes annually while improving delivery reliability and ensuring our customers get what they need, when they need it."

Descartes' route planning and execution platform helps building supply distributors manage the complexity of last mile delivery where high-value materials, specialized handling and tight delivery commitments are the norm. The solution enables more centralized and consistent dispatch operations across locations, while dynamically optimizing routes based on real-world constraints, such as delivery windows, vehicle capacity and traffic. This helps ensure efficient delivery execution while keeping contractor jobs on schedule. It also maximizes route density and vehicle capacity use to increase deliveries per route without increasing fleet size, and provides end-to-end visibility to drive continuous fleet performance improvement, higher productivity, lower fuel consumption and reduced emissions.

"Fuel is one of the largest and most volatile expenses in fleet operations, especially for building materials distributors managing multi-stop job site deliveries," said James Wee, General Manager, Fleet Management at Descartes. "With more intelligent routing and better visibility into daily operations, companies can reduce unnecessary miles and fuel consumption, centralize dispatch operations across locations, and improve overall fleet performance, all of which helps to keep customers' construction projects on schedule."

For more information, visit Descartes Building Supply Resource Center.***

MoneyHero Group to Announce First Quarter 2026 Results

Thu, 11 Jun 2026 13:20:00 +0700

HONG KONG and SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- MoneyHero Limited (Nasdaq: MNY) ("MoneyHero" or the "Company"), a leading tech- and AI-powered personal finance aggregation and comparison platform and a digital insurance brokerage provider in Greater Southeast Asia, today announced that it will release its first quarter 2026 results on Wednesday, June 24, 2026 before market opens and will hold a related conference call to discuss the results at 8:00 a.m. EDT (or 8:00 p.m. Hong Kong / Singapore time) on the same day.

Investors and other interested parties may listen to the call by clicking on the registration link for the webcast or audio conference at:
Webcast: https://edge.media-server.com/mmc/p/b7wwzyug
Conference call: https://register-conf.media-server.com/register/BIc910046ad194431c9631e21c 0745482 f
The webcast replay will be available on the Investor Relations website for 12 months following the event.

About MoneyHero Group
MoneyHero Limited (NASDAQ: MNY) is a tech- and AI-powered personal finance aggregation and comparison platform that provides consumers with actionable insights to discover, compare, and choose the best financial products with confidence -- bringing data intelligence and seamless digital access across insurance and banking solutions. The Company operates in Singapore, Hong Kong, Taiwan and the Philippines. Its brand portfolio includes B2C platforms MoneyHero, SingSaver, Money101, Moneymax and Seedly, as well as the B2B platform Creatory. The Company also retains an equity stake in Malaysian fintech company, Jirnexu Pte. Ltd., parent company of Jirnexu Sdn. Bhd., the operator of RinggitPlus, Malaysia's largest operating B2C platform. MoneyHero had over 300 commercial partner relationships as at December 31, 2025, and had approximately 4.2 million Monthly Unique Users across its platform for the year ended December 31, 2025. The Company's backers include Peter Thiel?co-founder of PayPal, Palantir Technologies, and the Founders Fund--and Hong Kong businessman, Richard Li, the founder and chairman of Pacific Century Group. To learn more about MoneyHero and how the innovative fintech company is driving APAC's digital economy, please visit www.MoneyHeroGroup.com.
For inquiries, please contact:
Investor Relations:
MoneyHero IR Team
IR@MoneyHeroGroup.com
Media Relations:
MoneyHero PR Team
Press@MoneyHeroGroup.com

JA Worldwide and IBM Expand Global Collaboration with Goal of Delivering AI and Digital Skills to Up to One Million High-School Students

Thu, 11 Jun 2026 13:02:00 +0700

The expanded initiative builds on successful pilot programs implemented across the JA network and will scale to more than two dozen countries.

BOSTON, June 10, 2026 (GLOBE NEWSWIRE) -- JA Worldwide and IBM today announced the expansion of their global collaboration through IBM SkillsBuild, IBM's free education program aimed at increasing access to technology education. The organizations have set a goal to deliver practical digital learning experiences to help one million high-school student learners build AI and technology skills needed for the future of work.

The expanded initiative builds on successful pilot programs implemented across the JA network and will scale to more than two dozen countries. Participating countries will span Africa, Asia Pacific, Europe, Latin America, the Middle East, and North America.

As one of the world's largest and most impactful youth-serving NGOs, JA Worldwide delivers hands-on, immersive learning in entrepreneurship, work readiness, and financial capability. Through this expanded global collaboration with IBM SkillsBuild, JA learners will gain access to industry-relevant digital and AI courses and credentials designed to help them build the skillset and mindset to thrive in an AI-driven economy.

"Artificial intelligence and digital technologies are transforming nearly every industry, creating extraordinary opportunity while also accelerating the need for new skills," said Asheesh Advani, CEO of JA Worldwide. "Through our expanded collaboration with IBM SkillsBuild, we're helping young people around the world gain access to future-focused learning experiences that increase confidence, expand opportunity, and prepare them to build thriving communities."

"Through JA Worldwide, we are helping students around the world build the technical and professional skills they need to participate confidently and responsibly in an AI-driven workforce," said Lydia Logan, Vice President, Global Education and Workforce Development, IBM.

The collaboration will combine IBM SkillsBuild content with JA's global implementation capabilities, educator networks, and localized delivery model. The first phase of implementation will reach 185,000 high-school students across participating countries, with projected growth to 600,000 learners in 2027 and a goal of reaching one million students by the end of 2028. The initiative will include courses focused on AI, professional skills, and career readiness, with content available in 15 languages.

In addition to digital learning experiences, the collaboration offers opportunities for learners to engage IBM employees as volunteer mentors, speakers, and career guides across participating countries, creating additional opportunities for young people to connect classroom learning to real-world careers and technology applications.

The three-year collaboration reflects a shared commitment to expanding economic opportunity and preparing the next generation for success in an increasingly digital world.***

Space42 Memperluas Kemampuan Observasi Bumi Setelah Tiga Satelit Foresight Beroperasi Penuh

Thu, 11 Jun 2026 12:50:00 +0700

* Foresight-3, -4, dan -5 kini beroperasi penuh setelah diluncurkan pada bulan November 2025

* Perluasan jangkauan meningkatkan frekuensi pemantauan ulang di wilayah-wilayah dengan permintaan tinggi

* Integrasi Synthetic Aperture Radar (SAR) dan kemampuan AI menghadirkan data intelijen yang cepat, dapat diandalkan, dan dapat diperoleh dalam segala kondisi cuaca

ABU DHABI, Uni Emirat Arab, June 10, 2026 (GLOBE NEWSWIRE) -- Space42, perusahaan SpaceTech berteknologi AI asal UEA dengan jangkauan global, hari ini mengumumkan bahwa satelit Foresight-3, Foresight-4, dan Foresight-5 telah beroperasi penuh. Pencapaian ini memperkuat konstelasi Foresight Earth Observation (EO), yang kini terdiri dari lima satelit Synthetic Aperture Radar (SAR) sehingga memungkinkan akuisisi data berkelanjutan dan intelijen geospasial berkualitas yang mendukung pengambilan keputusan.

Ketiga satelit tersebut diproduksi melalui kemitraan dengan ICEYE di Finlandia, untuk mendukung transfer teknologi dan akses berkelanjutan terhadap kapabilitas tersebut, sekaligus melokalkan rantai pasok. Sejalan dengan mandat tersebut, proses integrasi dan pengujian penting telah diselesaikan di fasilitas Assembly, Integration and Testing (AIT) untuk Sistem Ruang Angkasa Space42 di Abu Dhabi.

Hasan Al Hosani, CEO Smart Solutions di Space42, mengatakan: "Dengan beroperasinya satelit Foresight-3, -4, dan -5, kami memperluas kemampuan observasi Bumi berdaulat dengan kecepatan dan konsistensi lebih tinggi untuk pemerintah, industri, dan mitra di seluruh dunia. Kolaborasi dengan ICEYE serta keberhasilan operasional yang telah terbukti di fasilitas Sistem Ruang Angkasa Space42 telah memperkuat kapabilitas nasional hingga mencapai tingkat yang mampu bersaing dan dapat diskalakan di pasar global. Konstelasi ini juga semakin mendukung strategi kami untuk menjadi mitra pilihan dalam penyediaan data geospasial premium, sekaligus memperkuat posisi UEA di industri yang dinamis dan krusial bagi keberhasilan misi."

Jangkauan Lebih Luas dan Wawasan Lebih Cepat

Foresight-3, -4, dan -5 diluncurkan ke Orbit Bumi Rendah berinklinasi menengah untuk memperluas jangkauan sehingga memperkuat pemantauan di berbagai wilayah strategis yang dihuni oleh lebih dari 90% penduduk bumi. Konstelasi Foresight menyediakan citra SAR bagi GIQ, platform intelijen geospasial berteknologi AI milik Space42, yang mengubah data mentah menjadi intelijen berkualitas yang mendukung pengambilan keputusan dalam hitungan menit. Dengan beroperasi di orbit yang saling melengkapi, sistem ini mampu mempertahankan performa yang konsisten di sepanjang waktu.

Sistem ini menghadirkan resolusi 25 sentimeter dan pencitraan dalam segala kondisi cuaca sehingga memungkinkan deteksi yang dapat diandalkan atas perubahan berskala kecil di Bumi dari ruang angkasa. GIQ memproses data ini menjadi output yang dapat ditindaklanjuti, sehingga membantu mengurangi waktu tanggap darurat hingga 90%, biaya pemeliharaan prediktif hingga 30%, serta inefisiensi operasional hingga 25%.

Permintaan Global dan Kepemimpinan UEA

Permintaan terhadap EO terus meningkat pesat ketika berbagai pemerintah dan industri makin mengandalkan intelijen geospasial untuk mengelola risiko, mengoptimalkan operasi, serta mendukung tujuan iklim dan keamanan. Paling lambat pada tahun 2030, wawasan EO diproyeksikan menghasilkan nilai ekonomi lebih dari 700 miliar dolar A.S. dan berkontribusi pada pengurangan emisi di berbagai sektor.

UEA kini memosisikan diri sebagai pemasok terkemuka untuk kapabilitas EO canggih, dengan dukungan Strategi Ruang Angkasa Nasional 2030-nya serta investasi di bidang infrastruktur berdaulat, integrasi AI, dan manufaktur lokal. Ekspansi konstelasi Foresight milik Space42 mendukung ambisi ini dengan menggabungkan akuisisi data berbasis ruang angkasa dan analitik berbasis AI.***

General Fusion Named World's Top GreenTech Company of 2026 by TIME

Thu, 11 Jun 2026 09:21:00 +0700

Recognition highlights the Company's progress toward commercial fusion energy as it advances plans to become a public company

VANCOUVER, British Columbia, June 09, 2026 (GLOBE NEWSWIRE) -- General Fusion Inc. ("General Fusion" or the "Company") has ranked first on TIME's prestigious list of the World's Top GreenTech Companies of 2026, a recognition for its innovation in fusion energy. The honor comes as General Fusion advances toward becoming a publicly listed company through its previously announced proposed business combination with Spring Valley Acquisition Corp. III ("Spring Valley") (NASDAQ: SVAC).

"Being named TIME's top GreenTech company of 2026 is a testament to the incredible work of our team and a recognition of our innovative approach to transforming the world's energy supply through fusion energy," said Greg Twinney, Chief Executive Officer of General Fusion. "For more than 20 years, we have been building and proving our technology. That experience has led to LM26, our world-first Magnetized Target Fusion demonstration machine, now in operation. We're on the path to industry-defining technical milestones to deliver practical fusion power in the next decade."

"We are honored to receive this recognition at a pivotal moment in our journey to become the first publicly traded pure-play fusion company," Twinney added. "Fusion has the potential to reshape global energy markets, but success depends on practical engineering, disciplined investment, and a clear path to commercialization. This award reflects our approach to developing fusion power plants that can deliver reliable, zero-carbon energy at scale."

Selected from more than 8,300 applicants worldwide, General Fusion was recognized by TIME and Statista Inc. for the transformative potential of its technology, which uniquely addresses critical barriers to practical fusion energy. Once commercialized, fusion has the potential to be a long-term solution to rising electricity demand, energy security concerns, and decarbonization goals. The full list of honorees was announced today on TIME's website. Statista publishes global industry rankings and company lists with leading media partners, drawing on research from statista.com, its data and business intelligence platform.

Quick Facts:

* General Fusion's Magnetized Target Fusion ("MTF") is designed to solve significant barriers to commercializing fusion energy at a time when electricity demand is surging, and nations around the world are racing to commercialize fusion power.

* As a technology, MTF aims to achieve fusion in a practical way, avoiding superconducting magnets and high-powered lasers, while enabling the use of existing materials for durable machines that would produce cost-effective energy.

* In early 2025, General Fusion announced that it had designed, built, and begun operating its world-first Lawson Machine 26 ("LM26") fusion demonstration machine in under two years. LM26 is the first MTF demonstration machine to be built at a commercially relevant scale. It mechanically compresses plasma with a lithium liner at 50% commercial-scale diameter.

* LM26 aims to achieve key fusion technical milestones: plasma heating to 1 keV (10 million degrees Celsius), then 10 keV (100 million degrees Celsius), and ultimately the Lawson criterion, the combination of fusion parameters that can produce net fusion energy in the plasma.***